Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University of Pécs and at the University of Debrecen Identification number: TÁMOP-4.1.2-08/1/A-2009-0011 Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University of Pécs and at the University of Debrecen Identification number: TÁMOP-4.1.2-08/1/A-2009-0011 Dr. Péter Balogh and Dr. Péter Engelmann Transdifferentiation and regenerative medicine – Lecture 8 LIVER REGENERATION FROM STEM CELLS TÁMOP-4.1.2-08/1/A-2009-0011 Structure of the hepatic lobe Bile canaliculi Central vein Central vein Portal tracts (triads) Sinusoids Portal tract Bile duct Branch portal Branch hepatic vein artery Periportal Centrilobular Glutamine synthetase + (6-8 cells) (8-10 cells) (1-3 cells) Limiting plate TÁMOP-4.1.2-08/1/A-2009-0011 Clinical necessity of liver regeneration • Shortage of livers for orthotopic liver transplantation • Liver cell transplantation – limited amount • Choice of stem cell candidates – variable success in experimental conditions Main phases of liver regeneration Physical/chemical/genetical 1 Migration stimulus TÁMOP-4.1.2-08/1/A-2009-0011 Gadolinium chloride/ monocrotaline 3 Clearance Organ damage MMP-9 Central vein 2 Integration VEGF Monocrotal ine Doxorubici n Hepatic injury VEGF Sinus endothel permeability Recruitment SDF-1 HGF (SCF) Stem cells c-kit, c-met, CXCR4) Organ damage HGF TGF FGF MMP-9 MMP-2 MT1-MMP Cell loss of Dead cell Kupffer cells Central vein (phagocytosis) Effector cells Immunosuppressi on Encapsulation Cotransplantation Central vein Alteration of blood flowVasodilatators Gap junctions Variable in vivo cell phenotype Developmental relationship between hepatic-pancreatic differentiation TÁMOP-4.1.2-08/1/A-2009-0011 ? Oval cell progenitor Pancreatic progenitor(s) Hepatic ovalPancreatic cell oval cell Bile duct HepatocyteEndocrine cell Pancreatic duct Acinar cell TÁMOP-4.1.2-08/1/A-2009-0011 Transcriptional control of hepatoblast development Hepatoblast HGF C/EBP HNF-6 Tbx3 HNF-1 HNF-4 Notch2 Hepatocyte Core transcription factor network: Albumin ECM ? Jagged Wnt BMP+FGF FoxM1B ECM Cholangiocyte Hex C/EBP TGF HNF-6/OC-2 HNF-4 HNF-1 HNF-6 LRH-1 Foxa2 HNF-1 Hepatocyte maturation cords Parenchyma Periportal HNF-1 Sox9 Cholangiocyte maturation ducts TÁMOP-4.1.2-08/1/A-2009-0011 Oval cells – adult liver stem/progenitor cells • Origin: debated (their precursors are associated with the biliary tree) • Bipotential differentiation: hepatocyte and cholangiocyte • Phenotype: shared markers with adult hepatocytes (albumin, cytokeratins 8 and 18), bile duct cells (cytokeratins 7 and 19, OV-6, A6), fetal hepatoblasts (AFP), and haematopoietic stem cells (Thy -1, Sca-1, c-kit). Cellular targets for hepatic regeneration TÁMOP-4.1.2-08/1/A-2009-0011 • Hepatocytes: metabolic activity of the liver • Cholangiocytes: formation of bile ducts • Both derive from embryonic endodermal epithelium. TÁMOP-4.1.2-08/1/A-2009-0011 Stages and forms of liver regeneration • Surgical partial hepatectomy – from hepatocytes (often polyploid cells) • Possible sources: hepatocytes, oval cells and extrahepatic stem cells (HSC?) • Assessment of lineage commitment: albumin, glucose-6-phosphatase, transferrin and transthyretin (hepatic). • Fibrotic regeneration: transformation of fibrocytes into myofibroblasts • Parenchymal regeneration: regeneration of hepatocytes TÁMOP-4.1.2-08/1/A-2009-0011 Sequence of parenchymal regeneration of the liver • Stem cell migration into the liver parenchyma is directed by chemoattractive agents (as SDF-1, HGF and SCF) secreted by damaged liver cells • Increased MMP-9 expression by host hepatocytes after injury, leading to ECM remodeling and increased vascular permeability • Transformation of local microenvironment for the integration and proliferation of the transplanted cells, including local secretion of cytokines/growth factors (HGF, FGF, TGF). Dead cells will be phagocyted by Kupffer cells. TÁMOP-4.1.2-08/1/A-2009-0011 Oval cell activation and expansion • Liver injury activates oval cells (their precursors in the biliary tree?) AND other support cells (stellate cells, macrophages/Kupffer’s cells, NK cells, endothelium, etc) • Homing/intrahepatic migration to the site of injury • Proliferation and bidirectional differentiation (hepatocyte/cholangiocyte) TÁMOP-4.1.2-08/1/A-2009-0011 Non-hepatic cells for liver regeneration Autologous: Bone marrowderived/mesenchymal stem cells – fibroblastic regeneration Allogenic: Fetal-derived hepatocytes or embryonic stem cell-derived liver cells TÁMOP-4.1.2-08/1/A-2009-0011 Differentiation of iPS cells into hepatocytes • Induction of iPS cells: transfection with TFs • Formation of embryoid bodies • Induction of endodermal commitment: treatment with Activin A and bFGF • Differentiation into hepatocytes: treatment with hepatocyte growth factor (HGF) • Assessment: gene expression, albumin secretion, glycogen storage, urea production, and inducible cytochrome activity TÁMOP-4.1.2-08/1/A-2009-0011 Summary • Depending on the origin/type of liver damage, different regeneration processes operate, thus (a) in loss of liver mass, the regeneration is initiated from hepatocytes, whereas (b) in toxicity from hepatocholangiocyte progenitors. • Oval cells as adult-type hepatocyte/cholangiocyte progenitors are most likely to be facultative stem cells, although cells with stem cell activity from extrahepatic sources may also operate in liver regeneration.